Singapore-listed iX Biopharma has secured a $112.07m (US$41m) contract from the US Department of Defense to fund late-stage development of Wafermine.

Chan said the government will adopt a “One plus Three” model for upstream research and development (R&D). Under the model, a ...

The global surgical equipment market is set to rise from $14.16b in 2025 to $27.40b by 2032, according to Maximize Market ...

The Australian Government will provide up to $85 million in 2026 to support research on serious health conditions with ...

The systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the seven major markets (7MM*) is set to grow ...